Similarly, insurers like Health New England are ending coverage for GLP1 weightloss drugs (Saxenda, Wegovy, Zepbound) for most commercial members as of January 1, 2026, unless their employer buys an optional rider
The FDAs message is narrower but sharper: it intends to take action against non-FDA-approved compounded GLP-1s that are mass-marketed as alternatives, and it warned that violations can lead to seizure or an injunction
2 Patients should be advised about the signs and symptoms of pancreatitis, even though this adverse event is considered to be rare
Therefore, semaglutide, a drug widely used to treat obesity, could influence not only weight loss but also body composition and muscle function
full brightening usually takes 6 to 10 sessions
Emergency Protocols : Established procedures for managing serious adverse reactions, including immediate access to medical care